Search - tctmd.com

Displaying 521 - 540 of 880

Sort: Relevancy | Date

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Shelley Wood

June 24, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

A New Biomarker to Diagnose Acute Myocarditis?

Todd Neale

June 03, 2021

News Daily News

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

L.A. McKeown

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Daily News

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Todd Neale

May 24, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Shelley Wood

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Conference News EHRA 2021

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

Todd Neale

April 26, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

Advertisement

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Less Cancer Among HF Patients Taking Statins, Registry Shows

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

A New Biomarker to Diagnose Acute Myocarditis?

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

‘Enormous’ QoL Improvements With Mavacamten in HCM

FDA Approves Dapagliflozin for CKD Patients

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content